Knowledge regarding medicines management of type 2 diabetes amongst patients attending a Community Health Centre in South Africa
Afsana Moosa
School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
Search for more papers by this authorSelente Bezuidenhout
School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
Search for more papers by this authorJohanna C. Meyer
School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
Search for more papers by this authorCorresponding Author
Brian Godman
School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
Division of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
Health Economics Centre, Liverpool University Management School, Liverpool, UK
Correspondence: Brian Godman, Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden.
E-mail: [email protected]
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
E-mail: [email protected]
Search for more papers by this authorAfsana Moosa
School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
Search for more papers by this authorSelente Bezuidenhout
School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
Search for more papers by this authorJohanna C. Meyer
School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
Search for more papers by this authorCorresponding Author
Brian Godman
School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
Division of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
Health Economics Centre, Liverpool University Management School, Liverpool, UK
Correspondence: Brian Godman, Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden.
E-mail: [email protected]
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
E-mail: [email protected]
Search for more papers by this authorAbstract
Objective
The prevalence of type 2 diabetes mellitus (T2DM) is growing in Sub-Saharan countries including South Africa. This is a concern given its appreciable impact on morbidity, mortality and costs with the recent introduction of universal health care in South Africa. The purpose of the study was to assess the knowledge of patients with T2DM attending a typical community health centre (CHC) regarding the management of their disease including risk factors and prevention to guide future initiatives. Typically, patients with T2DM in South Africa are managed in ambulatory care including CHCs.
Method
A quantitative, descriptive study in a CHC. The sample included 217 adults with T2DM who have visited a physician as well as the pharmacy. Face-to-face patient exit interviews were conducted using a structured questionnaire.
Key findings
Females predominated (65%), with the majority of patients >60 years (38.2%) and more than half from the Indian racial category. Most patients did not know how their medication controls their diabetes (79.3%) or did not know any of the side effects (83.9%) from their medication. Less than half of the patients knew how to take their medication, and more than a third of patients indicated that they were not practicing any form of self-care.
Conclusion
The results indicate that these T2DM patients lacked sufficient knowledge regarding the management of their disease. Healthcare managers should consider instigating programmes to improve patients’ knowledge about the management of their disease as part of general initiatives within South Africa to improve the management of patients with chronic diseases in the public sector.
References
- 1 WHO. World Health Organisation, Diabetes Fact sheet July 2016. http://www.who.int/mediacentre/factsheets/fs312/en/
- 2 IDF Diabetes Atlas 8th Edition 2017. http://www.diabetesatlas.org/resources/2017-atlas.html.
- 3Ofori-Asenso R et al. Overweight and obesity epidemic in Ghana-a systematic review and meta-analysis. BMC Public Health 2016; 16: 1239.
- 4Werfalli M et al. The prevalence of type 2 diabetes among older people in Africa: a systematic review. Lancet Diabetes Endocrinol 2016; 4: 72–84.
- 5Ottermann B. Prevalence of diabetes in South Africa. Jan 2017. https://www.health24.com/Medical/Diabetes/About-diabetes/Diabetes-tsunami-hits-South-Africa-20130210.
- 6 Statistics South Africa. Mortality and causes of death in South Africa, 2016: Findings from death notification. http://www.statssa.gov.za/publications/P03093/P030932016.pdf.
- 7Cois A, Day C. Obesity trends and risk factors in the South African adult population. BMC Obes 2015; 2: 42.
- 8Lloyd-Sherlock P et al. Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control. Int J Epidemiol 2014; 43: 116–128.
- 9Rampamba EM et al. Knowledge of hypertension and its management among hypertensive patients on chronic medicines at primary health care public sector facilities in South Africa; findings and implications. Expert Rev Cardiovasc Ther 2017; 15: 639–647.
- 10 National Department of Health South Africa. Strategic plan for the prevention and control of non-communicable diseases 2013-17. 2013. file:///C:/Users/mail/Desktop/My%20documents/Ongoing%20papers/South%20Afica%20Moosa/ZAF_B3_NCDs_STRAT_PLAN_1_29_1_3[2].pdf.
- 11 International Diabetes Federation. IDF Diabetes Atlas 7th edition. https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html.
- 12Al-Rifai RH, Aziz F. Prevalence of type 2 diabetes, prediabetes, and gestational diabetes mellitus in women of childbearing age in Middle East and North Africa, 2000-2017: protocol for two systematic reviews and meta-analyses. Syst Rev 2018; 7: 96.
- 13Holman N et al. Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK. Diabet Med 2015; 32: 1119–1120.
- 14 World Health Organization. Global Report on Diabetes. 2016. file:///C:/Users/mail/Desktop/My%20documents/Ongoing%20papers/South%20Afica%20Moosa/WHO%20Global%20report%20on%20diabetes%202016.pdf.
- 15Iqbal Q et al. Profile and predictors of health related quality of life among type II diabetes mellitus patients in Quetta city, Pakistan. Health Qual Life Outcomes 2017; 15: 142.
- 16 The Lancet Diabetes & Endocrinology. The ageing of Africa. Lancet Diabetes Endocrinol 2016; 4: 1.
- 17Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 2008; 88: 1322–1335.
- 18Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004; 27: 1218–1224.
- 19Cramer JA et al. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract 2008; 62: 76–87.
- 20Rwegerera GM et al. Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future. Alexandria J Med 2018; 54: 103–109.
- 21Rwegerera GM. Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study. Pan Afr Med J 2014; 17: 252.
- 22Iqbal Q et al. Assessment of medication adherence among type 2 diabetic patients in Quetta city, Pakistan. Postgrad Med 2017; 129: 637–643.
- 23Kalyango J et al. Non-adherence to diabetes treatment at Mulago hospital in Uganda: prevalence and associated factors. Afr Health Sci 2008; 8: 67–73.
- 24Sefah IA et al. Adherence to oral anti-diabetic medicines among type 2 diabetes mellitus patients in the Volta Region of Ghana. Fourth Training Workshop and Symposium MURIA Group in conjunction with ISPE 2018 Consolidated abstracts p21. file:///C:/Users/mail/Downloads/Consolidated-abstract-booklet%20(3)pdf.
- 25 World Health Organisation. Adherence to long-term therapies: evidence for action. 2003. file:///C:/Users/mail/Desktop/My%20documents/Ongoing%20papers/South%20Afica%20Moosa/WHO%20Adherence%20to%20long%20term%20therapies.pdf.
- 26Divya S, Nadig P. Factors contributing to non-adherence to medication among type 2 diabetes mellitus in patients attending tertiary care hospital in South India. Asian J Pharm Clin Res 2015; 8: 274–276.
- 27Basaran NF, Akici A. Patients’ experience and perspectives on the rational use of drugs in Turkey: a survey study. Patient Prefer Adherence 2012; 6: 719–724.
- 28Mash B et al. A morbidity survey of South African primary care. PLoS ONE 2012; 7: e32358.
- 29 Department Health Republic of South Africa. National health insurance for South Africa towards universal health coverage. https://www.health-e.org.za/wp-content/uploads/2015/12/National-Health-Insurance-for-South-Africa-White-Paper.pdf
- 30Meyer JC et al. Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa. a preliminary study. Front Pharmacol 2017; 8: 751.
- 31Moosa A et al. Knowledge of type-2 diabetes among patients attending a community health centre in Pretoria, South Africa: patient centered treatment and care. Afr J Phys Health Educ Recr Dance 2015; Suppl 2: 241–251. https://journals.co.za/content/ajpherd/21/sup-2?page=3.
- 32Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence 2016; 10: 1299–1307.
- 33Islam SM et al. Patients’ perspective of disease and medication adherence for type 2 diabetes in an urban area in Bangladesh: a qualitative study. BMC Res Notes 2017; 10: 131.
- 34Gulabani M et al. Knowledge of diabetes, its treatment and complications amongst diabetic patients in a tertiary care hospital. Indian J Community Med 2008; 33: 204–206.
- 35Kenaope T et al. Characteristics and outcomes of patients attending a tertiary care diabetic centre in botswana; findings and implications. Fourth Training Workshop and Symposium MURIA Group in conjunction with ISPE 2018. Consolidated abstracts p22. file:///C:/Users/mail/Downloads/Consolidated-abstract-booklet%20(3)pdf.
- 36Jackson IL et al. Knowledge of self-care among type 2 diabetes patients in two states of Nigeria. Pharm Pract 2014; 12: 404.
- 37Hilawe EH et al. Differences by sex in the prevalence of diabetes mellitus, impaired fasting glycaemia and impaired glucose tolerance in sub-Saharan Africa: a systematic review and meta-analysis. Bull World Health Organ 2013; 91: 671–82d.
- 38Browne DL et al. What do patients with diabetes know about their tablets? Diabet Med 2000; 17: 528–531.
- 39Thungathurthi STS, Kumar GV. Self care knowledge on diabetes among diabetic patients in Warangal region. Int J Life Sci Pharma Res 2012; 2: P-16–P-21. http://ijlpr.com/admin/php/uploads/79_pdf.pdf.
- 40Hajwal SK, Salma K. Assessment of self-care knowledge among type II diabetics mellitus patients at diabetic center in Babylon governorate/Iraq. Int J Sci Res Publ 2016; 6: 281–291. http://www.ijsrp.org/research-paper-0816/ijsrp-p5637.pdf.
- 41Krishnan V, Thirunavukkarasu J. Assessment of knowledge of self blood glucose monitoring and extent of self titration of anti-diabetic drugs among diabetes mellitus patients - a cross sectional, community based study. J Clin Diagn Res 2016; 10: Fc09–Fc11.
- 42Wabe NT et al. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. North Am J Med Sci 2011; 3: 418–423.
- 43Karaoui LR et al. Knowledge and practice of patients with diabetes mellitus in Lebanon: a cross-sectional study. BMC Public Health 2018; 18: 525.
- 44Ssemaluulu R, Adome R. Patients’ knowledge of medication use as an equity issue in health care: Do health workers pay attention to this? EQUINET Project 2006. http://www.equinetafrica.org/sites/default/files/uploads/documents/CBP3EHSadome.pdf.
- 45Williams L et al. A survey of patients’ knowledge of their diabetes medication. J Diabetes Nurs 2007; 264-9 p.
- 46Saleh F et al. Knowledge and self-care practices regarding diabetes among newly diagnosed type 2 diabetics in Bangladesh: a cross-sectional study. BMC Public Health 2012; 12: 1112.
- 47Kerr M et al. Cost of diabetic foot disease to the National Health Service in England. Diabet Med 2014; 31: 1498–1504.
- 48Oksuz E et al. Cost of illness among patients with diabetic foot ulcer in Turkey. World J Diabetes 2016; 7: 462–469.
- 49Raghav A et al. Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always. Ther Adv Endocrinol Metab 2018; 9: 29–31.
- 50Smith M. Pharmacists’ role in improving diabetes medication management. J Diabetes Sci Technol (Online) 2009; 3: 175–179.
- 51Erku DA et al. The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study. Pharm Pract 2017; 15: 1026.
- 52Antoine S-L et al. Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials. BMC Endocr Disord 2014; 14: 53.
- 53Rampamba EM et al. Satisfaction, experiences and perceptions of hypertensive patients with primary healthcare services in Vhembe District, South Africa. Fourth Training Workshop and Symposium MURIA Group in conjunction with ISPE 2018 Consolidated abstracts p24. file:///C:/Users/mail/Downloads/Consolidated-abstract-booklet%20(3)pdf.
- 54Egbujie BA et al. Role of community health workers in type 2 diabetes mellitus self-management: a scoping review. PLoS ONE 2018; 13: e0198424.
- 55Gorina M et al. Effectiveness of primary healthcare educational interventions undertaken by nurses to improve chronic disease management in patients with diabetes mellitus, hypertension and hypercholesterolemia: a systematic review. Int J Nurs Stud 2018; 86: 139–150.
- 56Rampamba EM et al. Evaluation of antihypertensive adherence and its determinants at primary healthcare facilities in rural South Africa. J Comp Eff Res 2018; 7: 661–672.
- 57Nashilongo MM et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther 2017; 31: 565–578.
- 58Jande M et al. Patient-related beliefs and adherence toward their medications among the adult hypertensive outpatients in Tanzania. J Comp Eff Res 2017; 6: 185–193.
- 59Houston TK et al. African American veterans storytelling: a multisite randomized trial to improve hypertension. Med Care 2017; 55: S50–S58.
- 60Houston TK et al. Culturally appropriate storytelling to improve blood pressure: a randomized trial. Ann Intern Med 2011; 154: 77–84.
- 61Veintramuthu S, et al. Role of pictograms in educating diabetes patients about medication use and lifestyle modifications. Indian Journal of Pharmacy Practice 2015; 8: 102–112.
10.5530/ijopp.8.3.4 Google Scholar
- 62Shrivastava SR et al. Role of self-care in management of diabetes mellitus. J Diabetes Metab Disord 2013; 12: 14.
